sustained monomorphic ventricular tachycardia ("VT") in patients with ischemic or non-ischemic structural heart disease. Adagio’s vCLAS TM Cryoablation System, which is currently the subject of ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

sustained monomorphic ventricular tachycardia ("VT") in patients with ischemic or non-ischemic structural heart disease. Adagio’s vCLAS TM Cryoablation System, which is currently the subject of an ...

What To Know: Adagio Medical says the system targets drug-resistant, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with ischemic or non-ischemic structural heart disease.

This system is aimed at treating drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with ischemic or non-ischemic structural heart disease. The FDA’s ...

If sustained, VT can become fatal. FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation in Recurring Monomorphic Ventricular Tachycardia) is a prospective, multi-center, open-label ...

sustained monomorphic ventricular tachycardia (VT) in patients with structural heart disease. CEO Todd Usen said the regulatory nod marked a significant milestone for Adagio as it validated its ...

If sustained, VT can become fatal. FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation in Recurring Monomorphic Ventricular Tachycardia) is a prospective, multi-center, open-label, ...

It aims to address the challenges of ventricular tachycardia (VT ... nonischemic structural heart disease patients with sustained monomorphic VT.” The company currently markets vCLAS for ...